Tarigan Simson, Huntley John F
Balai Penelitian Veteriner, Jalan R.E. Martadinata 30, P.O. Box 151, Bogor 16114, Indonesia.
Vet Parasitol. 2005 Oct 10;133(1):101-9. doi: 10.1016/j.vetpar.2005.03.044.
Developing an anti-scabies vaccine is thought to be a feasible alternative to chemical control, since animals which have recovered from sarcoptic mange become resistant against mite reinfestation. The purpose of this study was to evaluate the protective value of immune responses developed in animals after immunisation with soluble mite proteins. Soluble proteins from Sarcoptes scabiei were extracted then subjected to ion exchange chromatography, and proteins from the column were eluted step-wise with 0%, 10%, 25% and 50% of 1 M solution of NaCl in a Tris buffer. Each protein fraction was concentrated and dialysed against PBS. To evaluate the immunogenicity of the fractions, 36 goats were allocated into six groups, group1 goats were unvaccinated, group 2 were vaccinated with intact soluble mite proteins, and groups 3-6 were vaccinated respectively with the fractionated proteins. Vaccinations were conducted four times with 1 mg protein/dose and 4-week intervals between vaccinations. One week after the last vaccination, all goats were challenged with approximately 2000 live mites on the auricles and infestations were allowed to progress for 6 weeks. The severity of lesions caused by the infestation was assessed throughout the study. The challenge caused mange or encrustation dermatitis in all animals and no differences in severity of lesions were observed between vaccinated and unvaccinated control goats. Vaccination with each fraction of the mite proteins invoked high levels of scabies-specific IgG in the serum of all animals but failed to induce specific IgE as determined by Elisa. In contrast, goats challenged experimentally with a primary or repeated mite challenge developed strong serum IgE and IgG antibody responses to Sarcoptes antigens. The latter animals were shown in a previous study to be resistant to reinfestation. The lack of immune protection in the vaccinated animals may be attributed to the absence of protective levels of IgE antibody, and the present findings indicate that allergens and IgE antibody is important in immunity to S. scabiei infection.
开发一种抗疥疮疫苗被认为是化学防治的一种可行替代方法,因为从疥螨病中康复的动物会对螨虫再次感染产生抗性。本研究的目的是评估动物在用可溶性螨蛋白免疫后产生的免疫反应的保护价值。从疥螨中提取可溶性蛋白,然后进行离子交换色谱分析,柱中的蛋白用Tris缓冲液中0%、10%、25%和50%的1 M NaCl溶液逐步洗脱。每个蛋白组分都进行浓缩并针对PBS进行透析。为了评估这些组分的免疫原性,将36只山羊分为六组,第1组山羊未接种疫苗,第2组用完整的可溶性螨蛋白接种疫苗,第3 - 6组分别用分级分离的蛋白接种疫苗。以1 mg蛋白/剂量进行四次接种,每次接种间隔4周。最后一次接种后一周,所有山羊在耳廓上接种约2000只活螨,让感染持续6周。在整个研究过程中评估感染引起的病变严重程度。感染在所有动物中都引起了疥螨病或结痂性皮炎,接种疫苗的山羊和未接种疫苗的对照山羊在病变严重程度上没有观察到差异。用螨蛋白的每个组分接种疫苗在所有动物的血清中都引发了高水平的疥疮特异性IgG,但通过酶联免疫吸附测定法确定未能诱导特异性IgE。相比之下,经初次或反复螨攻击实验性攻击的山羊对疥螨抗原产生了强烈的血清IgE和IgG抗体反应。在先前的一项研究中表明,后一组动物对再次感染具有抗性。接种疫苗的动物缺乏免疫保护可能归因于缺乏保护性水平 的IgE抗体,目前的研究结果表明变应原和IgE抗体在对疥螨感染的免疫中很重要。